Hypoxic pulmonary hypertension (HPH) is a lethal disease. CircRNAs and m 6 A 33 circRNAs have been reported to be associated with cancer progression, but the 34 expression profiling of m 6 A circRNAs has not been identified in HPH. This study was 35 to investigate the transcriptome-wide map of m 6 A circRNAs in HPH. In this study, 36 hypoxia-induced PH rat model was established. Total RNA was extracted and purified 37 from lungs of rats, then circRNAs were detected and annotated by RNA-seq analysis. 38 m 6 A RNA Immunoprecipitation (MeRIP) was performed following rRNA depletion, 39 and RNA-seq library was constructed. CircRNA-miRNA-mRNA co-expression 40 network was also constructed. In vitro, total m 6 A was measured. m 6 A circXpo6 and 41 m 6 A circTmtc3 were detected in pulmonary artery smooth muscle cells (PASMCs) and 42 pulmonary artery endothelial cells (PAECs) exposed to 21% O 2 and 1% O 2 for 48 h, 43 respectively. m 6 A abundance in 166 circRNAs was significantly upregulated and m 6 A 44 abundance in 191 circRNAs was significantly downregulated in lungs of HPH rats. 45 m 6 A abundance in circRNAs was significantly reduced in hypoxia in vitro. m 6 A 46 circRNAs were mainly derived from single exons of protein-coding genes. m 6 A 47 influenced the circRNA-miRNA-mRNA co-expression network in hypoxia. m 6 A 48 circXpo6 and m 6 A circTmtc3 were downregulated in hypoxia. In general, our study 49 firstly identified the transcriptome-wide map of m 6 A circRNAs in HPH. m 6 A level in 50 circRNAs was decreased in lungs of HPH rats and in PASMCs and PAECs exposed to 51 hypoxia. Downregulated or upregulated m 6 A level influenced circRNA-miRNA-52 mRNA co-expression network in HPH. Moreover, we firstly identified two 53 downregulated m 6 A circRNAs in HPH: circXpo6 and circTmtc3. We suggested that 54 m 6 A circRNAs may be used as a potential diagnostic marker or therapy target in the 55 future.
Interestingly, circRNAs can be m 6 A-modified. m 6 A circRNAs displayed cell-type-146 specific methylation patterns in human embryonic stem cells (hESCs) and HeLa cells 147 (14). CircRNAs contained m 6 A modifications are likely to promote protein translation 148 in a cap-independent pattern (9). However, m 6 A circRNAs has not been elucidated in 149 HPH yet. Here we are the first to identify the correlation between m 6 A modification 150 and circRNAs abundance in HPH. compared with the control (0.25  0.03 vs. 0.44  0.04, p = 0.001, Fig 1C) . The medial 160 wall of the pulmonary small arteries was also significantly thickened (19.28  2.19% 161 vs. 39.26  5.83%, p < 0.001, Fig 1D and 1E) . Moreover, in the normoxia group, 53.82 162 ± 3.27% of the arterioles were non-muscularized (NM) vessels, and 25.13 ± 1.83% 163 were fully muscularized (FM) vessels. In contrast, partially muscularized vessels (PM) 164 and FM vessels showed a greater proportion (32.88 ± 3.15% and 41.41 ± 3.35%) in 165 HPH rats, while NM vessels occupied a lower proportion (25.71 ± 2.55%) (Fig 1F) . 166 Fig 1G displayed the heatmap of m 6 A circRNAs expression profiling in normoxia (N) 167 and hypoxia (HPH). m 6 A abundance in 166 circRNAs was significantly upregulated. 168 Meanwhile, m 6 A abundance in 191 circRNAs was significantly downregulated (S1 169 Table, filtered by fold change  4 and p  0.00001). Lungs of N and HPH rats were 170 selected to measure m 6 A abundance in purified circRNAs. The m 6 A level in total 171 circRNAs isolated from lungs of HPH rats was lower than that from controls (Fig 1H) . 172 Moreover, over 50% circRNAs contained only one m 6 A peak either in lungs of N or 173 HPH rats (Fig 1I) . 174 175 m 6 A circRNAs were mainly from protein-coding genes spanned single exons in N 176 and HPH groups 177 We analyzed the distribution of the parent genes of total circRNAs, m 6 A-circRNAs, 178 and non-m 6 A circRNAs in N and HPH, respectively. N and HPH groups showed a 179 similar genomic distribution of m 6 A circRNAs and non-m 6 A circRNAs (Fig 2A and   180   2B ). Moreover, about 80% of m 6 A circRNAs and non-m 6 A circRNAs were derived 7 181 from protein-coding genes in both groups. A previous report indicated that most 182 circRNAs originated from protein-coding genes spanned two or three exons (14) . While 183 in our study, over 50% and 40% of total circRNAs from protein-coding genes spanned 184 one exon in N and HPH groups, respectively (Fig 2C and 2D) . Similarly, m 6 A 185 circRNAs and non-m 6 A circRNAs were mostly encoded by single exons. Therefore, it 186 was indicated that m 6 A methylation was abundant in circRNAs originated from single 187 exons in N and HPH groups. The length of DE m 6 A circRNAs was mostly enriched in 1-10000 bps (Fig 3A) . The peaks. In the GO analysis (Fig 3C, left) , the parent genes of circRNAs with upregulated 199 m 6 A peaks were enriched in the protein modification by small protein conjugation or 200 removal and macromolecule modification process in the biological process (BP).
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Organelle and membrane-bounded organelle were also the two largest parts in the 202 cellular component (CC) analysis. Binding and ion binding were the two main 203 molecular functions (MF). The top 10 pathways from KEGG pathway analysis were 204 selected in the bubble chart (Fig 3C, right) . Among them, the oxytocin signaling (Fig 3D, right) . Construction of a circRNA-miRNA-mRNA co-expression network in HPH 228 We found 76 upregulated circRNAs with increased m 6 A abundance, and 107 229 downregulated circRNAs with decreased m 6 A abundance (Fig 5A, S2 Table) . As 230 known, circRNAs were mostly regarded as a sponge for miRNAs and regulated the 231 expression of corresponding target genes of miRNAs (28). To explore whether 232 circRNAs with DE m 6 A abundance influence the availability of miRNAs to target 233 genes, we selected DE circRNAs with increased or decreased m 6 A abundance. GO 234 enrichment analysis and KEGG pathway analysis were also performed to analyze target and binding in MF part. In the KEGG pathway analysis, the top 10 most enriched 240 pathways were selected (Fig 5D and 5E ). Wnt and FoxO signaling pathways were 9 241 reported to be involved in PH progression (29-31). Then, we analyzed the target genes 242 involved in these two pathways (S1 Fig and S2 Fig) . SMAD4 was associated with PH 243 and involved in Wnt signaling pathways. MAPK3, SMAD4, TGFBR1, and CDKN1B 244 were involved in FoxO signaling pathways. To explore the influence of circRNA-245 miRNA regulation on PH-associated genes expression, we constructed a circRNA-246 miRNA-mRNA network, integrating matched expression profiles of circRNAs, 247 miRNAs and mRNAs (Fig 5F and 5G) . MicroRNAs sponged by the target genes of
let-7g-5p, and miR-205 were analyzed because they were reported to be associated with 250 PH (32, 33). We filtered the key mRNAs and miRNAs, and founded that the two 251 circRNAs were the most enriched, which were originated from chr1:204520403- vs. 0.059%  0.008, p = 0.031 in PAECs, Fig 6A) . m 6 A abundance in circRNAs was 259 lower than it in mRNAs (0.1-0.4%) (17, 18). Next, we confirmed the back-splicing of 260 circXpo6 and circTmtc3 by CIRI software. The sequence of linear Xpo6 and Tmtc3 261 mRNA was analyzed. Then we identified that circXpo6 was spliced form exon 7, 8, 262 and 9 of Xpo6. CircTmtc3 was spliced form exon 8, 9, 10, and 11 (Fig 6B) . Using (Fig 6D and 6E) . m 6 A circXpo6 and m 6 A circTmtc3 were 269 significantly decreased in PASMCs and PAECs when exposed to hypoxia (p = 0.002, 270 and p = 0.015 in PASMCs and p = 0.02, and p = 0.047 in PAECs) In this study, we identified the transcriptome-wide map of m 6 A circRNAs in hypoxic 274 pulmonary hypertension. On the whole, we found that m 6 A level in circRNAs was 275 reduced in lungs when exposed to hypoxia. m 6 A circRNAs were mainly derived from 
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Our study found that m 6 A abundance in total circRNAs was decreased by hypoxia 303 exposure. Moreover, our study indicated that circXpo6 and circTmtc3 were the novel Competing endogenous RNA (ceRNA) mechanism was proposed that mRNAs, 319 pseudogenes, lncRNAs and circRNAs interact with each other by competitive binding 320 to miRNA response elements (MREs) (40, 41). m 6 A acts as a post-transcript regulation 321 of circRNAs and influences the expression of circRNAs, thus we suggested that m 6 A 322 could also regulate the circRNA-miRNA-mRNA co-expression network. When the 323 circRNAs were classified, we found that these downstream targets regulated by However, limitations still exist in the study. First, we did not analyze the m 6 A level 340 between circRNAs and the host genes. Second, the exact mechanism of hypoxia 341 influences m 6 A was not demonstrated. Lastly, the function of circXpo6 and circTmtc3 342 in HPH was not elaborated.
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In conclusion, our study firstly identified the transcriptome-wide map of m 6 A circRNAs 345 in HPH. m 6 A level in circRNAs was decreased in lungs of HPH and in PASMCs and 346 PAECs exposed to hypoxia. m 6 A level influenced circRNA-miRNA-mRNA co-347 expression network in HPH. Moreover, we firstly identified two downregulated m 6 A 348 circRNAs in HPH: circXpo6 and circTmtc3. We suggest that circRNAs can be used as 349 biomarkers because it is differentially enriched in specific cell types or tissues and not 350 easily degraded (6). Also, the aberrant m 6 A methylation may contribute to tumor 351 formation and m 6 A RNAs may be a potential therapy target for tumor (17). Therefore, 352 we suppose that m 6 A circRNAs may also be used as a potential diagnostic marker or 
